Home

Email Majestueus Onderscheid magmaris markers position Verlaten Gluren som

Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library

Magmaris
Magmaris

SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice - ScienceDirect
SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice - ScienceDirect

Magmaris
Magmaris

Magmaris
Magmaris

First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ...
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial ...

Magmaris
Magmaris

Magmaris
Magmaris

Magmaris
Magmaris

Magmaris
Magmaris

Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca
Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca

Magmaris
Magmaris

Impact of strut dimensions and vessel caliber on thrombosis risk of bioresorbable scaffolds using hemodynamic metrics
Impact of strut dimensions and vessel caliber on thrombosis risk of bioresorbable scaffolds using hemodynamic metrics

Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds - CRTonline
Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds - CRTonline

Magmaris™ resorbable magnesium scaffold: state-of-art review | Future Cardiology
Magmaris™ resorbable magnesium scaffold: state-of-art review | Future Cardiology

Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent - Barkholt - 2020 - Catheterization and Cardiovascular Interventions - Wiley Online Library

Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca
Documento di posizione SICI-GISE sull'uso dello scaffold riassorbibile Magmaris nella pratica clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca

Magmaris
Magmaris

Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman
Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman

Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman
Mechanical properties of the drugâ•'eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a perman

PDF) BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients
PDF) BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients

First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffol
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffol

Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds | Circulation: Cardiovascular Interventions
Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds | Circulation: Cardiovascular Interventions